Human Clara cell protein,CC16 ELISA Kit 酶联免疫试剂盒-武汉华美生物

Human Clara cell protein,CC16 ELISA Kit

产品详情

引用文献

产品评价

相关产品

靶点详情

Most popular with customers

产品中心

信号通路

技术信息

联系信息

产品详情

产品描述：

CUSABIO人克拉拉细胞蛋白（CC16）酶联免疫检测试剂盒（货号：CSB-E08680h），采用双抗体夹心法定量检测血清、血浆及组织匀浆样本中的CC16蛋白浓度。CC16是一种由呼吸道上皮细胞分泌的免疫调节蛋白，广泛分布于支气管肺泡灌洗液和循环系统中，其表达水平与肺部炎症、哮喘、慢性阻塞性肺病（COPD）等呼吸道疾病密切相关，是评估肺组织损伤和炎症反应的重要生物标志物。试剂盒检测范围为0.625-40 ng/ml，可精准识别微量样本中的目标蛋白，适用于基础科研中探索肺部疾病机制、评估环境污染物或药物对肺功能的影响、以及相关动物模型研究中的生物标志物分析。试剂盒包含预包被特异性抗体的酶标板、标准品及检测所需全套试剂，操作流程标准化，支持科研人员高效完成样本中CC16的定量分析，为呼吸系统疾病研究、毒理学实验及生物医学机制探索提供可靠工具。
别名：

Blastokinin ELISA Kit; CC10 ELISA Kit; CC16 ELISA Kit; CCPBP ELISA Kit; CCSP ELISA Kit; Clara cell phospholipid binding protein ELISA Kit; Clara cell phospholipid-binding protein ELISA Kit; Clara cell specific 10 kD protein ELISA Kit; Clara cells 10 kDa secretory protein ELISA Kit; OTTHUMP00000236107 ELISA Kit; SCGB1A1 ELISA Kit; Secretoglobin family 1A member 1 ELISA Kit; Secretoglobin, family 1A, member 1 (uteroglobin) ELISA Kit; UG ELISA Kit; UGB ELISA Kit; UP-1 ELISA Kit; UP1 ELISA Kit; Urinary protein 1 ELISA Kit; Urine protein 1 ELISA Kit; UTER_HUMAN ELISA Kit; Uteroglobin ELISA Kit
缩写：

CC16
Uniprot No.：

P11684
种属：

Homo sapiens (Human)
样本类型：

serum, plasma, tissue homogenates
检测范围：

0.625 ng/ml - 40 ng/ml
灵敏度：

0.156 ng/ml
反应时间：

1-5h
样本体积：

50-100ul
检测波长：

450 nm
研究领域：

Others
测定原理：

quantitative
测定方法：

Sandwich

精密度：

线性度：

To assess the linearity of the assay, samples were spiked with high concentrations of human CC16 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

	Sample	Serum(n=4)
1:20	Average %	104
	Range %	97-110
1:40	Average %	98
	Range %	91-106
1:80	Average %	99
	Range %	92-105
1:160	Average %	90
	Range %	86-97

回收率：

标准曲线：

These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

ng/ml

OD1

OD2

Average

Corrected

2.283

2.334

2.309

2.158

1.562

1.667

1.615

1.464

1.020

1.028

1.024

0.873

0.644

0.629

0.637

0.486

2.5

0.402

0.391

0.397

0.246

1.25

0.288

0.273

0.280

0.129

0.625

0.206

0.194

0.200

0.049

0.147

0.155

0.151

本试剂盒所含材料：
显示更多

收起更多
本试剂盒不含材料：
显示更多

收起更多
数据处理：

ELISA操作视频及标曲绘制软件下载
货期：

3-5 working days

引用文献

相关产品

靶点详情

最新研究进展：

CC16是一种肺泡表面活性蛋白，具有免疫抑制和抗炎作用，可用于肺疾病的诊断和监测。最新研究发现，CC16水平与慢性阻塞性肺疾病、哮喘、肺部感染等多种呼吸系统疾病相关，并且可能参与心血管疾病和神经系统疾病的发生发展。
功能：

Binds phosphatidylcholine, phosphatidylinositol, polychlorinated biphenyls (PCB) and weakly progesterone, potent inhibitor of phospholipase A2.
基因功能参考文献：
1. There was no evidence that serum CC16 levels played a role in recurrent wheezing and a positive asthma predictive index in pre-school children PMID: 29685782
2. Data suggest that the increase in plasma club cell protein (CC16) CC16 following inhaled allergen as a biomarker of epithelial dysfunction. PMID: 28862880
3. We propose that increased CC-16 levels is a marker of lung inflammatory response that associated with ventilatory insufficiency are related to impending respiratory failure, not fully predicted by conventional respiratory tests PMID: 28967121
4. Studied serum CC16 levels in The serum CC16 levels in Acute respiratory distress syndrome (ARDS) and non-ARDS patients; found CC16 to be were significantly higher in ARDS patients than that in non-ARDS patients. PMID: 28548310
5. Studied serum CC16 levels in relation to atopy and previously manifested low respiratory tract diseases. Found low serum CC16 is associated with previously expressed pneumonia and chronic wheezing in atopic children. PMID: 28146340
6. Our data suggest that rCC16 suppresses LPS-mediated inflammatory mediator TNF-alpha, IL-6, and IL-8 production by inactivating NF-kappaB and p38 MAPK but not AP-1 in RAW264.7 cells. PMID: 28338974
7. There were associations between urinary CC16 and arsenic concentration in soil, water, house dust, and dust loading. In multiple analyses, only the concentration of arsenic in soil was associated with urinary CC16 levels after accounting for other factors. PMID: 27223295
8. findings demonstrate that CC16 is upregulated in IPF patients suggesting that may participate in its pathogenesis. PMID: 27977812
9. The G38A CCSP gene polymorphism may alter either the production of the protein and/or its activity in chronic obstructive pulmonary disease. PMID: 27496897
10. CC16 levels differed among idiopathic pulmonary fibrosis, pulmonary sarcoidosis and chronic pulmonary obstructive disease. PMID: 27758987
11. Lung-specific (CC-16) and novel (RelB) biomarkers are associated with systemic cardiovascular changes over time. CC-16 can predict subsequent exacerbations in subjects with severe COPD and may be an important biomarker of pulmonary and systemic stress in COPD. PMID: 26914709
12. The serum concentration of CC16 was significantly higher in patients with lung fibrosis. PMID: 25244495
13. lower levels of urine CC16 and lung function in patients with asthma than in those patients without asthma. CC16 in urine may be a useful tool or biomarker for investigating lung epithelium integrity among children with asthma or lung injury. PMID: 26108072
14. Smokers and COPD patients had reduced airway CC16 immunostaining that decreased with increasing COPD severity. PMID: 25700379
15. the uteroglobin G38A gene polymorphism was not associated with IgAN risk PMID: 25068828
16. Sputum and bronchoalveolar lavage fluid CC16 were significantly higher in patients with severe asthma compared to mild-moderate asthma and healthy controls. PMID: 25728058
17. In chromium-exposed workers, blood levels of CC16, and CC16/SP-D were lower than in controls. Positive relationships were shown between CC16 or CC16/SP-D and indicators of lung function. PMID: 25851191
18. KL-6 levels were higher and CC16 levels were lower in infants with poor neurodevelopmental outcome compared with those infants who had favourable neurodevelopmental outcome. PMID: 25631862
19. CC16 may play an important protective role in cigarette smoke-related diseases. PMID: 25635997
20. A meta-analysis indicated that the CC16 gene A38G polymorphism is not associated with the risk of asthma. PMID: 25743006
21. Increased plasma clara cell secretory protein levels are associated with primary graft dysfunction. PMID: 24400993
22. Uteroglobin is a possible ligand of the lipoxin receptor and it may have a role in inhibiting serum amyloid A-driven inflammation PMID: 24782597
23. Athletes with decreased serum CC16 from regular high-load exercise are more susceptible to respiratory infections. PMID: 24735334
24. A single therapeutic dose of terbutaline offers significant protection against hyperpnoea-induced bronchoconstriction and reduces urinary CC16 protein levels. PMID: 24030662
25. Lung permeability biomakers [surfactant protein D (SP-D) and Clara cell secretory protein (CC16) in plasma] and forced expiratory volumes and flow were measured in swimmers in indoor swimming pool waters treated with different disinfection methods. PMID: 23874631
26. Serum CC-16 is associated with disease progression in chronic obstructive pulmonary disease (COPD). However, the absence of CC-16 does not appear to modify the risk of cigarette-related COPD in mice. PMID: 24245748
27. Acute exposure to smoke induces injury at the alveolar level, which results in a transient increase of CC16 in serum of exposed subjects. PMID: 23258467
28. These results suggest that the CC16 A38G polymorphism may play a role in asymptomatic airway hyper-responsiveness and contribute to the development of late-onset asthma. PMID: 24125144
29. The SCGB1A1 +38A/G polymorphism is a risk factor for asthma. [Meta-analysis] PMID: 23820082
30. urinary CC16 may be a useful biomarker of increased lung epithelial permeability among female non-smokers; further work will be required to evaluate its applicability to males PMID: 22805990
31. Clara cell secretory protein expression changes is a relevant marker in the development of bronchiolitis obliterans patients with lung transplantation. PMID: 22883104
32. Overview of CC16 in pathophysiology of and as a biomarker in chronic obstructive pulmonary disease. PMID: 23030587
33. A Genome wide association study for COPD biomarkers on subjects with COPD found 2 discrete loci affecting CC16, one near the CC16 coding gene (SCGB1A1) on chromosome 11 and one approximately 25Mb away from SCGB1A1, identified in expressed sputum. PMID: 23144326
34. Donor CCSP A38G polymorphism is associated with decreased CCSP levels early after lung transplantation and poor long-term outcomes. PMID: 22902791
35. Exercise caused an increase in urinary excretion of CC16 in all subjects (P < 0.001), but this rise in CC16 was blunted following inhalation of warm humid air. PMID: 21799131
36. demonstration that cc-10 is differentially expressed in infants with iRDS may point the way towards one possible mechanism that potentially involves modifications of the protein structure with its anti-inflammatory and surfactant protective function PMID: 22613976
37. CC10 G+38A variant may contribute to the severity of asthma and lower level of steroid responsiveness. PMID: 22788242
38. These results indicate that CC10 gene transfer may inhibit airway inflammation through suppressing the activation of NF-kappaB. PMID: 22558282
39. Serum Clara cell secretory protein levels were characterized by an early postnatal surge. This apparent gestation-influenced surge may represent an initiation of a protective cascade against postnatal lung injury during extrauterine adaptation. PMID: 21952535
40. Single-nucleotide polymorphism in the CC10 gene (A38G) does not seem to be involved in the severity of respiratory syncytial virus infection or wheezing. PMID: 21767304
41. Urinary levels of CC16 are increased after eucapnic voluntary hyperpnea. PMID: 21131866
42. Elevated circulating CC16 levels identified severe thoracic injury combined with a strong correlation with the extent/volume of affected lung tissue. PMID: 21045740
43. CC16 38A/38A genotype plays a role in the development of early asthma in children with AR. PMID: 21255142
44. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. PMID: 21299834
45. In the context of allergic airway responses, CC10 can inhibit OPN expression and suppress the Th2-promoting function of OPN, resulting in CC10's inhibitory biological effects. PMID: 20553297
46. Data suggest that a supernatant of non-small-cell lung cancer causes an imbalance in the immune response of PBMCs and DCs, which is reversed by CC-10. PMID: 20664959
47. Letter: serum CCSP cannot be used as a biomarker predictive for bronchiolitis obliterans after lung transplantation. PMID: 20683434
48. Reduced anti-inflammatory CC10 concentrations in airways of extremely premature infants with a fetal inflammatory response, not umbilical cord serum CC10, might make their lungs susceptible for further postnatal injuries. PMID: 19887851
49. Association of CC16 with daily outdoor particulate matter from combustion sources increases epithelial barrier permeability in lungs. PMID: 19852548
50. The effect of G38A may be apparent under stimulation as sex steroids or infections, and homozygotes of the G38A mutation cannot produce sufficient UG in response to stimulation and may be predisposed to IgA nephropathy, especially in childhood. PMID: 11774099
显示更多

收起更多
亚细胞定位：

Secreted.
蛋白家族：

Secretoglobin family
组织特异性：

Clara cells (nonciliated cells of the surface epithelium of the pulmonary airways).
数据库链接：

HGNC: 12523

OMIM: 192020

KEGG: hsa:7356

STRING: 9606.ENSP00000278282

UniGene: Hs.523732

Intra-assay Precision (Precision within an assay): CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess.

Inter-assay Precision (Precision between assays): CV%<10%

Three samples of known concentration were tested in twenty assays to assess.